Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
283 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02941926 | Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC(COMPLEEMENT-1) | completed | Phase 3 | 3,246 | Novartis PharmaceuticalsINDUSTRY | 38 | Oct 24, 2023 | clinicaltrials |
| NCT04721002 | Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)(MEDICI) | completed | — | 514 | AbbVieINDUSTRY |
| 22 |
| Oct 18, 2023 |
| clinicaltrials |
| NCT05871320 | Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms(TECANT) | completed | Early Phase 1 | 10 | Jagiellonian UniversityOTHER | 3 | Sep 29, 2023 | clinicaltrials |
| NCT03809988 | PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)(PALMIRA) | completed | Phase 2 | 198 | MedSIROTHER | 6 | Sep 7, 2023 | clinicaltrials |
| NCT05907577 | Early Detection of Lung Cancer With Machine Learning Based on Routine Clinical Investigations | unknown | — | 7,500 | The University Clinic of Pulmonary and Allergic Diseases GolnikOTHER | 1 | Jun 18, 2023 | clinicaltrials |
| NCT04864951 | HPV Prevalence in Transpersons - a Prospective Study | completed | N/A | 203 | Sophie PilsOTHER | 2 | Mar 15, 2023 | clinicaltrials |
| NCT02869399 | Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention(DietINT) | completed | N/A | 94 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 6 | Mar 13, 2023 | clinicaltrials |
| NCT04939961 | Effects of Hericium Erinaceus on Microbiota and Cognition(HE) | completed | N/A | 40 | University of PrimorskaOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT00858364 | Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy | terminated | Phase 3 | 2,549 | AmgenINDUSTRY | 37 | Nov 30, 2022 | clinicaltrials |
| NCT05624827 | The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2) | unknown | N/A | 100 | University Medical Centre MariborOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT02425891 | A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130) | completed | Phase 3 | 902 | Hoffmann-La RocheINDUSTRY | 40 | Jul 19, 2022 | clinicaltrials |
| NCT04665531 | Postoperative Analgesia With a Catheter Under the Erector Spinae Muscle for Videothoracoscopic Lung Surgery(ESCAV) | completed | N/A | 50 | Surgery BitencOTHER | 1 | Jul 19, 2022 | clinicaltrials |
| NCT01702571 | A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment | completed | Phase 3 | 2,185 | Hoffmann-La RocheINDUSTRY | 43 | Apr 4, 2022 | clinicaltrials |
| NCT02978716 | Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) | terminated | Phase 2 | 102 | G1 Therapeutics, Inc.INDUSTRY | 8 | Mar 23, 2022 | clinicaltrials |
| NCT01077154 | Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) | terminated | Phase 3 | 4,509 | AmgenINDUSTRY | 39 | Sep 28, 2021 | clinicaltrials |
| NCT04921553 | Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING)(TRacKING) | unknown | — | 500 | Centre Leon BerardOTHER | 11 | Aug 2, 2021 | clinicaltrials |
| NCT02291133 | Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)(ECT-HCC) | completed | Phase 1 / Phase 2 | 25 | Masa BosnjakOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT01743989 | A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.(ENESTPath) | completed | Phase 3 | 620 | Novartis PharmaceuticalsINDUSTRY | 21 | Jul 15, 2021 | clinicaltrials |
| NCT01211483 | Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 222 | Daiichi SankyoINDUSTRY | 13 | Jun 16, 2021 | clinicaltrials |
| NCT04665544 | Tracers for Endometrial Cancer Sentinel Node Labeling(TESLA-1) | unknown | N/A | 83 | University Medical Centre MariborOTHER | 3 | Jun 14, 2021 | clinicaltrials |
| NCT04891081 | Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease | unknown | — | 50 | University Medical Centre LjubljanaOTHER | 1 | May 18, 2021 | clinicaltrials |
| NCT04859361 | Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ | unknown | N/A | 104 | University Medical Centre MariborOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT01345526 | Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream | completed | Phase 2 | 124 | Universitätsmedizin MannheimOTHER | 2 | Apr 30, 2021 | clinicaltrials |
| NCT01566721 | A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer(SafeHER) | completed | Phase 3 | 2,577 | Hoffmann-La RocheINDUSTRY | 59 | Apr 27, 2021 | clinicaltrials |
| NCT02352259 | Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II | completed | Phase 2 | 23 | Institute of Oncology LjubljanaOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT00296010 | Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer(CASA) | terminated | Phase 3 | 77 | ETOP IBCSG Partners FoundationNETWORK | 9 | Feb 23, 2021 | clinicaltrials |
| NCT00004179 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | completed | Phase 3 | 475 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 18 | Feb 15, 2021 | clinicaltrials |
| NCT01264952 | Treatment of Liver Metastases With Electrochemotherapy(ECTJ) | completed | Phase 1 / Phase 2 | 16 | Institute of Oncology LjubljanaOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT04062045 | Efficacy of Continous Regional Anesthesia Using m. Erector Spinae Catheter After VATS Procedures | unknown | N/A | 50 | Surgery BitencOTHER | 1 | Nov 13, 2020 | clinicaltrials |
| NCT04616703 | Natural History of NFAI: 10 Year Follow-up Results | unknown | — | 65 | University Medical Centre LjubljanaOTHER | 1 | Nov 5, 2020 | clinicaltrials |
| NCT03643055 | 18F-Fluorocholine PET/CT in Medullary Thyroid Cancer | unknown | — | 80 | University Medical Centre LjubljanaOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT01704716 | High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) | recruiting | Phase 3 | 3,300 | St. Anna KinderkrebsforschungOTHER | 20 | Oct 23, 2020 | clinicaltrials |
| NCT01572038 | A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer(PERUSE) | completed | Phase 3 | 1,436 | Hoffmann-La RocheINDUSTRY | 39 | Sep 25, 2020 | clinicaltrials |
| NCT00625898 | BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab(BETH) | terminated | Phase 3 | 3,509 | NSABP Foundation IncNETWORK | 40 | Sep 10, 2020 | clinicaltrials |
| NCT03246659 | Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC(GRAN-T-MTC) | completed | Phase 1 | 16 | Paola Anna ErbaOTHER | 5 | Mar 20, 2020 | clinicaltrials |
| NCT03755856 | Long-term Outcomes for Acute Myeloid Leukemia Patients(1621-QLG-LG) | unknown | — | 343 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 8 | Mar 4, 2020 | clinicaltrials |
| NCT02031458 | A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer(BIRCH) | completed | Phase 2 | 667 | Hoffmann-La RocheINDUSTRY | 19 | Jan 6, 2020 | clinicaltrials |
| NCT02236637 | A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care | completed | — | 3,050 | Janssen Pharmaceutica N.V., BelgiumINDUSTRY | 15 | Nov 12, 2019 | clinicaltrials |
| NCT01905943 | A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia | completed | Phase 3 | 979 | Hoffmann-La RocheINDUSTRY | 31 | Oct 28, 2019 | clinicaltrials |
| NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | completed | Phase 3 | 1,072 | Eli Lilly and CompanyINDUSTRY | 26 | Sep 25, 2019 | clinicaltrials |
| NCT04073082 | Safety and Efficacy of Laser Therapy in Gynaecology | unknown | — | 300 | Juna d.o.o.INDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT04043221 | Long Term Metformin in Women With Polycystic Ovary Syndrome | completed | — | 180 | University Medical Centre LjubljanaOTHER | 1 | Aug 2, 2019 | clinicaltrials |
| NCT02302807 | A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] | completed | Phase 3 | 931 | Hoffmann-La RocheINDUSTRY | 29 | Aug 1, 2019 | clinicaltrials |
| NCT01125566 | LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment | completed | Phase 3 | 508 | Boehringer IngelheimINDUSTRY | 38 | Jul 18, 2019 | clinicaltrials |
| NCT01367665 | STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | completed | Phase 2 | 1,232 | Hoffmann-La RocheINDUSTRY | 37 | Jun 6, 2019 | clinicaltrials |
| NCT00952380 | Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients | completed | Phase 2 | 38 | PfizerINDUSTRY | 5 | Apr 16, 2019 | clinicaltrials |
| NCT03838718 | REtroperitoneal SArcoma Registry: an International Prospective Initiative(RESAR) | recruiting | — | 2,000 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 11 | Feb 12, 2019 | clinicaltrials |
| NCT03553589 | Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma(BioEndoCar) | unknown | — | 400 | Andrea RomanoOTHER | 3 | Dec 5, 2018 | clinicaltrials |
| NCT00777101 | Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer | completed | Phase 2 | 233 | Puma Biotechnology, Inc.INDUSTRY | 31 | Aug 9, 2018 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials